ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD29 Antibody [JB1B] (A280765)

This product is discontinued

Anti-CD29 Antibody [JB1B] (A280765) has been discontinued and is no longer available.

View all CD29 Antibodies.

Name
Anti-CD29 Antibody [JB1B]
Description
Mouse anti Human CD29
Specificity
Mouse anti Human CD29 antibody, clone JB1B recognizes human integrin beta1, also known as CD29, Fibronectin receptor subunit beta, Glycoprotein IIa or VLA-4 subunit beta. CD29 is a 798 amino acid ~130 kDa single pass type-1 transmembrane glycoprotein containing a single VWFA domain. Specificity for CD29 has been confirmed with integrin beta1 transfectants and by reciprocal preclearing of beta1 reactivity with anti-beta1 antibody.Mouse anti Human CD29 antibody, clone JB1B has been successfully employed for the detection of porcine CD29 in formalin fixed, paraffin embedded material (Papageorgiou et al. 2014) and also to stimulate the adherence of several cell types (Wilkins et al. 1996).The removal of azide is recommended prior to use in functional assays.
Applications
WB, IP, Flow Cytometry, IHC-Fr, ELISA
Reactivity
Human, Cynomolgus Monkey, Porcine, Rhesus Monkey
Immunogen
Purified Human beta1 integrin.
Host
Mouse
Clonality
Monoclonal
Clone ID
JB1B
Isotype
IgG2a
Conjugate

Unconjugated

Purification
Protein A chromatography.
Concentration
500 µg/ml
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.09% Sodium Azide.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Synonyms
Fibronectin receptor subunit beta, FNRB, Glycoprotein IIa, GPIIA, Integrin beta-1, ITGB1, MDF2, MSK12, VLA-4 subunit beta
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.

Alternative products to Anti-CD29 Antibody [JB1B] (A280765)

Proteins predicted to interact with Integrin beta 1

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score